November 09, 2023 (Earnings Report) Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Real Good Food Company, Inc. Class A
Symbol: RGF
Recent Price: $1.78
Average Analyst Price Target: $7.33 (311.80%)
Market Cap: $71.32M
Last Year's EPS: 0.03
Consensus EPS Forecast: -0.27
Expected Earnings Date: 2023-08-14
Recent Analyst Action: Bill Chappell, analyst at Truist Financial, reiterates coverage on Real Good Food Company, Inc. Class A (RGF) in the Consumer Defensive sector with a Buy rating and a price target of $4 (3 weeks ago).
TipRanks.com also reports that Real Good Food Company, Inc. Class A currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.33 . The target pricing ranges from a high forecast of $7 down to a low forecast of $11. Real Good Food Company, Inc. Class A (RGF)’s last closing price was $1.78 which would put the average price target at 311.80% upside.Here are 3rd party ratings for RGF:
Recent Analyst Action: John Newman, analyst at Canaccord Genuity, reiterates coverage on Ocuphire Pharma (OCUP) in the Healthcare sector with a Buy rating and a price target of $22 (6 days ago).
TipRanks.com also reports that Ocuphire Pharma currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.40 . The target pricing ranges from a high forecast of $25 down to a low forecast of $17. Ocuphire Pharma (OCUP)’s last closing price was $3.04 which would put the average price target at 533.22% upside.Here are 3rd party ratings for OCUP:
Recent Analyst Action: Tim Chiang, analyst at Capital One Financial, reiterates coverage on Jasper Therapeutics (JSPR) in the Healthcare sector with a Buy rating and a price target of $7 (2 months ago).
TipRanks.com also reports that Jasper Therapeutics currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.37 . The target pricing ranges from a high forecast of $8 down to a low forecast of $4. Jasper Therapeutics (JSPR)’s last closing price was $0.80 which would put the average price target at 773.04% upside.Here are 3rd party ratings for JSPR:
Recent Analyst Action: Vijay Rakesh, analyst at Mizuho Securities, reiterates coverage on Interlink Electronics (LINK) in the Consumer Cyclical sector with a Buy rating and a price target of n/a (3 weeks ago).
TipRanks.com also reports that Interlink Electronics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.00 . The target pricing ranges from a high forecast of $21 down to a low forecast of $21. Interlink Electronics (LINK)’s last closing price was $10.91 which would put the average price target at 92.43% upside.Here are 3rd party ratings for LINK:
Recent Analyst Action: Robert LeBoyer, analyst at Noble Financial, reiterates coverage on Tonix Pharma (TNXP) in the Healthcare sector with a Buy rating and a price target of $10 (2 months ago).
TipRanks.com also reports that Tonix Pharma currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.00 . The target pricing ranges from a high forecast of $8 down to a low forecast of $10. Tonix Pharma (TNXP)’s last closing price was $0.49 which would put the average price target at 1940.82% upside.Here are 3rd party ratings for TNXP:
Recent Analyst Action: Neil Kalton, analyst at Wells Fargo, reiterates coverage on Algonquin Power & Utilities (AQN) in the Utilities sector with a Buy rating and a price target of $8 (1 week ago).
TipRanks.com also reports that Algonquin Power & Utilities currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $7.30 . The target pricing ranges from a high forecast of $8.5 down to a low forecast of $6. Algonquin Power & Utilities (AQN)’s last closing price was $5.62 which would put the average price target at 35.41% upside.Here are 3rd party ratings for AQN:
Recent Analyst Action: Michael Diana, analyst at Maxim Group, reiterates coverage on Sky Harbour Group (SKYH) in the Real Estate sector with a Buy rating and a price target of $11 (3 weeks ago).
TipRanks.com also reports that Sky Harbour Group currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $11.00 . The target pricing ranges from a high forecast of $11 down to a low forecast of $11. Sky Harbour Group (SKYH)’s last closing price was $6.95 which would put the average price target at 58.27% upside.Here are 3rd party ratings for SKYH:
To Your Financial Future,
The Editor, WallStreetSectors.com